Greenwich LifeSciences Inc.

GLSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.65

-$1.70 (-10.40%)

At close: Nov 5, 2026, 4:00 PM ET

$15.23

+$0.58 (+3.96%)

After-hours: Nov 5, 2026, 5:04 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-19.36M	-15.79M	-8.89M	-7.83M	-4.57M	-1.86M
Depreciation & Amortization	1.78K	3.61K	3.61K	3.61K	3.61K	3.61K
Stock-Based Compensation	6.8M	7.25M	2.38M	1.74M	660.58K	677.99K
Other Working Capital	568.12K	344.11K	-3.97K	-122.27K	141.57K	120.95K
Other Non-Cash Items	n/a	n/a	n/a	1.75M	1.19M	777.76K
Deferred Income Tax	n/a	n/a	n/a	-1.75M	-1.19M	-777.76K
Change in Working Capital	2.64M	1.27M	31.5K	-122.27K	-385.17K	28.4K
Operating Cash Flow	-9.91M	-7.27M	-6.48M	-6.2M	-4.29M	-1.15M
Capital Expenditures	3	3	n/a	-3	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-360K
Common Stock Repurchased	n/a	n/a	n/a	-7.54M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	-275.15K	n/a
Financial Cash Flow	12M	4.37M	n/a	-7.54M	2.84M	29.81M
Net Cash Flow	2.09M	-2.9M	-6.48M	-13.74M	-1.46M	28.65M
Free Cash Flow	-9.91M	-7.27M	-6.48M	-6.2M	-4.29M	-1.15M
Adj. Free Cash Flow	-16.72M	-14.52M	-8.86M	-7.94M	-4.95M	-1.83M
Maintenance CapEx	-3	-3	n/a	-3	n/a	n/a
Growth CapEx	6	6	n/a	n/a	n/a	n/a
Owner Earnings	-9.91M	-7.27M	-6.48M	-6.2M	-4.29M	-1.15M